The Royal Wolverhampton NHS Trust, New Cross Hospital

Wolverhampton WV10 0QP

2 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer Metastatic, End Stage Kidney Disease, Multiple Myeloma, Primary Membranous Nephropathy, Ulcerative Colitis

Studies at this site

• Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis — Stopped early
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer — Completed